Deliver Your News to the World

CybeRelease: (OTC: THII) CEO Featured on Yahoo! Finance


WEBWIRE

(CybeRelease, August 28, 2006) - Lake Harmony, PA -Tasco Holdings International, (OTCBB: THII) the parent company of wholly-owned subsidiary Bio-Matrix Scientific Group, Inc. which focuses on stem cell cryogenics and disposable stem cell / tissue transfer instruments, is pleased to announce that Mr. David Koos, Tasco Holdings Chairman and CEO, was recently interviewed by the Yahoo! Small Cap Centre (finance.yahoo.ca)

Mr. Koos discusses a wide range of topics including the growing importance of the Biotechnology sector including the Company’s Stem Cell Banking Facility, the recent acquisition of assets, the Company’s current and future prospects.

The Yahoo! Finance Canada Small Cap Centre focuses specifically on emerging small cap companies. The Yahoo! Small Cap Centre caters to an audience of small cap investors that are in search of exciting and compelling information within the small cap realm.

To access the Small Cap Centre - Powered By AGORACOM, please visit Yahoo! Finance Canada at http://ca.finance.yahoo.com and scroll through the middle column.

Alternatively, to access the interview page directly, please click on the link below.

http://cosmos.bcst.yahoo.com/scp_v3/viewer/index.php?pid=16390&rn=222561&cl=649973&ch=222671

To read the complete release, go to http://www.cyberelease.com/thii82806.htm

CybeRelease Gainers are ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA), Denny’s Corporation (Nasdaq: DENN), SeaBright Insurance Holdings, Inc. (Nasdaq: SEAB), Immunomedics, Inc. (Nasdaq: IMMU), Netflix, Inc. (Nasdaq: NFLX), Extreme Networks, Inc. (Nasdaq: EXTR), SuperGen, Inc. (Nasdaq: SUPG) and Finish Line, Inc. (The) (Nasdaq: FINL).

CybeRelease Decliners are Compuware Corporation (Nasdaq: CPWR), Hoku Scientific, Inc. (Nasdaq: HOKU), Cumulus Media Inc. (Nasdaq: CMLS), Movie Gallery, Inc. (Nasdaq: MOVI), TRM Corporation (Nasdaq: TRMM), WiderThan Co., Ltd. (Nasdaq: WTHN), Penn National Gaming, Inc. (Nasdaq: PENN) and Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. The company has hired and paid CybeRelease $995.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.



WebWireID19179





This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.